Table 3

Included studies involving asymptomatic and symptomatic participants

AuthorStudy designStudy populationParticipants (hips, n)DemographicsImaging modalityFindings (intra-articular pathology)
Dickenson et al 67*Cross-sectional Subjects
Male golfers with hip pain
Controls
Male golfers without hip pain
Subjects
NR (15)
Controls
NR (95)
Subjects
Age: NR
Sex: 15 M
Controls
Age: NR
Sex: 95 M
1.5 T MRI Subjects
Labral tear: 3/15; increased labral signal: 3/15; acetabular cartilage defect 4/15; femoral cartilage defect: 1/15; acetabular subchondral oedema: 3/15; femoral subchondral oedema: 6/15; herniation pit: 4/15; joint effusion: 1/15
Controls
Labral tear: 22/95; increased labral signal: 21/95; acetabular cartilage defect: 6/95; femoral cartilage defect: 3/95 acetabular subchondral oedema: 10/95; femoral subchondral oedema: 10/95; herniation pit: 9/95; joint effusion: 8/95
Ji et al 56 Case–control Subjects
Mechanical symptoms with hip pain
Controls
Pain due to a ureter stone without hip pain
Subjects
151 (151)
Controls
151 (151)
Subjects
Age†: 46 (12)
Sex: 83 F/68 M
Controls
Age†: 46 (12)
Sex: 83 F/68 M
CTACT Subjects
Herniation pit: 36/151
Controls
Herniation pit: 5/151
Kolo et al 51 Cross-sectional Subjects
Symptomatic/asymptomatic ballet dancers
Controls
Asymptomatic non-dancing individuals
Subjects
30 (59)
Controls
14 (28)
Subjects
Age‡: 24.6 (§18–39)
Sex: 30 F
Controls
Age‡: 27.1 (§20–34)
Sex: 14 F
1.5 T MRI Subjects
Labral tear: 28/59; hips≥2 labral tears: 12/59; labral degeneration: 24/59; hips≥2 labral degenerative tears: 11/59; labral ossification: 2/59; hips≥2 ossified lesions: 2/59; acetabular cartilage defect≤5 mm: 12/59; acetabular cartilage defect:≥5 mm: 17/59 herniation pit: 31/59
Controls
Labral tear: 8/28; hips≥2 labral tears: 1/28; labral degeneration: 12/28; hips≥2 labral degenerative tears: 1/28; labral ossification: 4/28; hips≥2 ossified lesions: 0/28; acetabular cartilage defect≤5 mm: 4/28; acetabular cartilage defect≥5 mm: 2/28; herniation pit: 5/28
Mayes et al 58*Case-control Subjects
Hip pain last 3 months¶
Controls
No hip pain¶
Subjects
NR (40)
Controls
NR (156)
Subjects
Age**††: 30 (IQR 24) Age**‡‡: 34.5 (IQR 24)
Sex¶: 24 F/9 M
Controls
Age**††: 30.5 (IQR 20)
Age**‡‡: 28 (IQR 20)
Sex¶: 32 F/33 M
3 T MRI Subjects
Labral tear: 16/40
Controls
Labral tear: 83/156
Mayes et al 43*Case–control Subjects
Hip pain last 3 months¶
Controls
No hip pain¶
Subjects
NR (40)
Controls
NR (156)
Subjects
Age**††: 30 (IQR 24) Age**‡‡: 34.5 (IQR 24)
Sex¶: 24 F/9 M
Controls
Age**††: 30.5 (IQR 20)
Age**‡‡: 28 (IQR 20)
Sex¶: 32 F/33 M
3 T MRI Subjects
Ligamentum teres tear: 20/40
Controls
Ligamentum teres tear: 38/156
Mayes et al 65*Case–control Subjects
Hip pain last 3 months¶
Controls
No hip pain¶
Subjects
NR (40)
Controls
NR (156)
Subjects
Age**††: 30 (IQR 24) Age**‡‡: 34.5 (IQR 24)
Sex¶: 24 F/9 M
Controls
Age**††: 30.5 (IQR 20)
Age**‡‡: 28 (IQR 20)
Sex¶: 32 F/33 M
3 T MRI Subjects
Cartilage defect: 18/40
Controls
Cartilage defect: 66/156
Teichtahl et al 68 Cross-sectional Subjects
Hip pain with radiographic hip OA
Controls
No hip pain
Subjects
19 (19)
Controls
141 (141)
Subjects
Age‡: 59.2 (7.6)
Sex: 11 F/8 M
Controls
Age‡: 66.8 (7.3)
Sex: 78 F/63 M
3 T MRI Subjects
Femoral head cartilage defect: central superolateral 17/19; central inferomedial 10/19; anterior: 12/19; posterior 14/19; acetabular cartilage defects: central superolateral 17/19; anterior 18/19; posterior 15/19; femoroacetabular cartilage defect: central superolateral 18/19; anterior 18/19; posterior 16/19; femoral head BML: central superolateral 10/19; central inferomedial 6/19; anterior 7/19; posterior 5/19; acetabular BML: central superolateral 13/19; central inferomedial 2/19; anterior 13/19; posterior 11/19; femoroacetabular BML: central superolateral 14/19; central inferomedial 6/19; anterior 14/19; posterior 13/19
Controls
Femoral head cartilage defect: central superolateral 45/141; central inferomedial 67/141; anterior 5/141; posterior 25/141; acetabular cartilage defects: central superolateral 37/141; anterior 26/141; posterior 50/141; femoroacetabular cartilage defect: central superolateral 64/141; anterior 27/141; posterior 57/141; femoral head BML: central superolateral 7/141; central inferomedial 6/141; anterior 2/141; posterior 4/141; acetabular BML: central superolateral 22/141; central inferomedial 3/141; anterior 28/141; posterior 18/141; femoroacetabular BML : central superolateral 27/141; central inferomedial 8/141; anterior 29/141; posterior 20/141
Tresch et al 66 Cross-sectional Subjects
Individuals with FAI
Controls
Asymptomatic individuals
Subjects
63 (63)
Controls
63 (63)
Subjects
Age‡: 35.3 (§20–50)
Controls
Age‡: 34.4 (§20–50)
1.5 T MRA
1.5 T MRI
Subjects
Labral tears: reader 1 37/63; reader 2 40/63; degenerated labrum: reader 1 6/63; reader 2 9/63; normal labrum: reader 1 20/63; reader 2 14/63; acetabular cartilage defect (superficial): reader 1 9/63; reader 2 21/63; acetabular cartilage defect (deep): reader 1 17/63; reader 2 12/63; normal acetabular cartilage: reader 1 37/63; reader 2 30/63 femoral cartilage defect (superficial): reader 1 13/63; reader 2 13/63; femoral cartilage defect (deep): reader 1 7/63; reader 2 5/63; normal femoral cartilage: reader 1 43/63; reader 2 45/63
Controls
Labral tears: reader 1 23/63; reader 2 33/63; degenerated labrum: reader 1 4/63; reader 2 8/63; normal labrum: reader 1 36/63; reader 2 22/63; acetabular cartilage defect (superficial): reader 1 5/63; reader 2 11/63; acetabular cartilage defect (deep): reader 1 0/63; reader 2 2/63; normal acetabular cartilage: reader 1 58/63; reader 2 50/63 femoral cartilage defect (superficial): reader 1 2/63; reader 2 3/63; femoral cartilage defect (deep): reader 1 0/63; reader 2 2/63; normal femoral cartilage: reader 1 61/63; reader 2 58/63
  • *Authors provided additional results not presented in original article.

  • †Median (SD).

  • ‡Mean (SD).

  • §Range.

  • ¶Includes dancers and athletes.

  • **Median (IQR).

  • ††Dancers.

  • ‡‡Athletes.

  • BML, bone marrow lesion; CTA, CT arthrography; F, female; FAI, femoroacetabular impingement; M, male; MRA, magnetic resonance arthrography; NR, not reported; OA, osteoarthritis.